Corteva, Inc.
NYSE:CTVAAgricultural Inputs
+$0.72 today
- Market cap
- $5.58B
- Beta
- 0.57
- P/E (TTM)
- 45.2
- EPS (TTM)
- $1.73
- Dividend yield
- 0.92%
Volume 22.41M
Average 3.82M
CTVA EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Corteva, Inc.NYSE: CTVA
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA remains negative
Q3 FY2026 EBITDA was -$208M, compared with -$24M a year earlier. Trailing-twelve-month EBITDA was $3.06B. Over 3 fiscal years it compounded at +4.0% a year.
Context
- EBITDA amounted to 17.6% of revenue in FY2025, up 1.5 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 6 analysts of $2.03B (-33.9%) for the fiscal year ending Dec 2026, a slowdown from the +12.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- -$208M-109.2% QoQ
- Last fiscal yearDec 2025
- $3.07B+12.3% YoY
- LTMSep 2026
- $3.06B-17.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -766.7% | +510.8% | +1277.5 pp |
| 1 year | +12.3% | -33.9% | -46.2 pp |
| 3-year CAGR | +4.0% | -15.6% | -19.6 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 3.07B USD
- Year-over-year change
- +12.3%
- 4-year CAGR
- -4.0%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.07B | +12.3% |
| FY2024 | 2024-12-31 | 2.74B | +7.8% |
| FY2023 | 2023-12-31 | 2.54B | -7.0% |
| FY2022 | 2022-12-31 | 2.73B | -24.6% |
| FY2021 | 2021-12-31 | 3.62B | — |
EBITDA vs competitors
How CTVA compares with its peers on the latest reported figures
- CTVA's LTM Sep 2026 EBITDA of $3.06B is the 2nd highest of the 7 companies compared; the peer median is $1.54B.
- Its year-over-year change of -17.3% is the 3rd highest of 7, against a peer median of -21.2%.
- EBITDA amounts to 17.3% of revenue for CTVA, versus a peer median of 11.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $6.3B | +26.2% | -21.6% | 22.3% | |
| LTM Sep 2026 | $3.06B | -17.3% | +4.0% | 17.3% | |
| LTM Sep 2026 | $3.02B | -18.2% | +4.0% | 17.1% | |
| LTM Sep 2026 | $1.6B | -56.7% | +4.0% | 9.1% | |
VYLRVylor Inc. | FY2025 | $1.48B | -24.1% | — | 14.7% |
| LTM Mar 2026 | -$6.25M | +83.4% | — | 1.2% | |
| LTM Mar 2026 | -$222.5M | -130.9% | — | 6.5% | |
| Peer median (excluding CTVA) | $1.54B | -21.2% | +4.0% | 11.9% | |
Competitors are the stored peer set for CTVA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 15.66B | 17.46B | 17.23B | 16.91B | 17.4B |
| Cost of Revenue | 9.22B | 10.44B | 9.92B | 9.53B | 9.17B |
| Gross Profit | 6.44B | 7.02B | 7.31B | 7.38B | 8.23B |
| Gross Margin | 41.1% | 40.2% | 42.4% | 43.6% | 47.3% |
| Research & Development | 1.19B | 1.22B | 1.34B | 1.4B | 1.47B |
| Selling, General & Admin | 3.21B | 3.17B | 3.18B | 3.2B | 3.49B |
| Operating Expenses | 5.12B | 5.09B | 5.2B | 5.28B | 5.61B |
| Depreciation & Amortization | 1.24B | 1.22B | 1.21B | 1.23B | 1.2B |
| EBITDA | 3.62B | 2.73B | 2.54B | 2.74B | 3.07B |
| EBITDA Margin | 23.1% | 15.6% | 14.7% | 16.2% | 17.6% |
| Operating Income | 1.32B | 1.93B | 2.11B | 2.1B | 2.62B |
| Operating Margin | 8.4% | 11.0% | 12.2% | 12.4% | 15.1% |
| Interest Income | 77M | 124M | 283M | 132M | 136M |
| Interest Expense | 30M | 79M | 233M | 233M | 180M |
| Other Income / Expenses | 1.03B | (502M) | (1.02B) | (821M) | (931M) |
| Income Before Tax | 2.35B | 1.43B | 1.09B | 1.28B | 1.69B |
| Pre-Tax Margin | 15.0% | 8.2% | 6.3% | 7.5% | 9.7% |
| Income Tax Expense | 524M | 210M | 152M | 412M | 484M |
| Net Income | 1.76B | 1.15B | 735M | 907M | 1.09B |
| Net Margin | 11.2% | 6.6% | 4.3% | 5.4% | 6.3% |
| EPS (Basic) | 2.39 | 1.59 | 1.04 | 1.31 | 1.60 |
| EPS (Diluted) | 2.37 | 1.58 | 1.03 | 1.30 | 1.60 |
| Weighted Avg Shares | 735.9M | 720.8M | 709M | 693.7M | 680M |
| Weighted Avg Shares (Diluted) | 741.6M | 724.5M | 711.9M | 696M | 681.4M |
Corteva, Inc.
NYSE:CTVA
Intrinsic Alpha fair value
Locked
Current Price
$8.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.